APA
Takeshita A., Asou N., Atsuta Y., Sakura T., Ueda Y., Sawa M., Dobashi N., Taniguchi Y., Suzuki R., Nakagawa M., Tamaki S., Hagihara M., Fujimaki K., Furumaki H., Obata Y., Fujita H., Yanada M., Maeda Y., Usui N., Kobayashi Y., Kiyoi H., Ohtake S., Matsumura I., Naoe T. & Miyazaki Y. (20190520). Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study. : Leukemia.
Chicago
Takeshita Akihiro, Asou Norio, Atsuta Yoshiko, Sakura Toru, Ueda Yasunori, Sawa Masashi, Dobashi Nobuaki, Taniguchi Yasuhiro, Suzuki Rikio, Nakagawa Masaru, Tamaki Shigehisa, Hagihara Maki, Fujimaki Katsumichi, Furumaki Hiroaki, Obata Yukako, Fujita Hiroyuki, Yanada Masamitsu, Maeda Yoshinobu, Usui Noriko, Kobayashi Yukio, Kiyoi Hitoshi, Ohtake Shigeki, Matsumura Itaru, Naoe Tomoki and Miyazaki Yasushi. 20190520. Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study. : Leukemia.
Harvard
Takeshita A., Asou N., Atsuta Y., Sakura T., Ueda Y., Sawa M., Dobashi N., Taniguchi Y., Suzuki R., Nakagawa M., Tamaki S., Hagihara M., Fujimaki K., Furumaki H., Obata Y., Fujita H., Yanada M., Maeda Y., Usui N., Kobayashi Y., Kiyoi H., Ohtake S., Matsumura I., Naoe T. and Miyazaki Y. (20190520). Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study. : Leukemia.
MLA
Takeshita Akihiro, Asou Norio, Atsuta Yoshiko, Sakura Toru, Ueda Yasunori, Sawa Masashi, Dobashi Nobuaki, Taniguchi Yasuhiro, Suzuki Rikio, Nakagawa Masaru, Tamaki Shigehisa, Hagihara Maki, Fujimaki Katsumichi, Furumaki Hiroaki, Obata Yukako, Fujita Hiroyuki, Yanada Masamitsu, Maeda Yoshinobu, Usui Noriko, Kobayashi Yukio, Kiyoi Hitoshi, Ohtake Shigeki, Matsumura Itaru, Naoe Tomoki and Miyazaki Yasushi. Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study. : Leukemia. 20190520.